A Brief Review for Managing Spasticity in Multiple Sclerosis

Journal Title: International Journal of Chronic Diseases & Therapy (IJCDT) - Year 2016, Vol 2, Issue 1

Abstract

Spasticity is a common problem in MS. The stiffness often is minimal and not bothersome. Stiffness may become painful and may interfere with performing activities of daily living. Reducing spasticity produces greater freedom of movement and strength and frequently also lessens fatigue and increases coordination. The major ways in which spasticity is reduced include stretching exercises, physical therapy, and the use of medications. If spasticity does not respond to these measures and causes discomfort, a surgical procedure may be necessary. These management methods discussed in brief here. Treat problems: The first management strategy is to alleviate associated problems that magnify spasticity. These include infection, pain, skin breakdown, and any similar process that may stimulate spasticity. Stretching: A thorough stretching program includes a series of exercises that are performed in certain sitting or lying positions that allow gravity to aid in stretching specific muscles. Some kind of these methods has been discussed in details in main page. Mechanical aids: Specific devices (orthose) sometimes are made for certain individuals to counteract spasticity and prevent what are termed contractures. Medications: Spasticity often is managed most effectively by medications such as Baclofen, Tizanidine, Dopa-agonists and Levodopa, Diazepam, Dantrolene, Cyproheptadin, Gabapentine and others that have been discussed in details in main page. BTX: A better, more modern technique is the use of botulinum toxin, made by bacteria. This paralytic agent causes a temporary blockage of the nerve and muscle. Intratecal baclofen: A better approach to the management of severe spasticity involves the use of a pump that delivers baclofen directly into the spinal canal. Surgical management : For those who have severe intractable spasticity, the kind that causes problems with all functions and is not responsive to exercise or medication, a spasticity-decreasing procedure may be necessary

Authors and Affiliations

Shabnam Pourabolghasem

Keywords

Related Articles

Cultural and Spiritual Dimension of Chronic Disease: An Important Concern for Practitioners

Cultural and Spiritual Dimension of Chronic Disease: An Important Concern for Practitioners

Dietary and Exercise Educational Program for Patients Taking Antipsychotic Medication

Problem: Overweight and obesity are significant problems in patients being treated with antipsychotic medications. Obesity has reached epidemic proportions in the United States, affecting over 72 million adults (Ogden, C...

Systematic Strategy Opinion for Research and Clinical Practice of Chronic Diseases

Systematic Strategy Opinion for Research and Clinical Practice of Chronic Diseases

Study of Prevalence of Martin-Gruber Anomaly in Patients with Carpal Tunnel Syndrome

Median-Ulnar connection in the forearm, also known as the Martin-Gruber communication (MGC), is a common anatomic nerve anomaly with the incidence from 5% to 34% in the normal population. Knowledge of this anomaly is o...

Premature Puberty in Obese Female Children Aged 5-17 in the United States for 2013-2014

The prevalence of obesity in female children in the Unites States has increased from 5% to 17.1% from 1965 to 2015 and the prevalence of premature puberty has increased as well. Increased weight is correlated with premat...

Download PDF file
  • EP ID EP212146
  • DOI 10.19070/2572-7613-160004
  • Views 109
  • Downloads 0

How To Cite

Shabnam Pourabolghasem (2016). A Brief Review for Managing Spasticity in Multiple Sclerosis. International Journal of Chronic Diseases & Therapy (IJCDT), 2(1), 17-20. https://europub.co.uk/articles/-A-212146